Does aspirin use reduce the risk of MACCE in patients with Takotsubo Syndrome?
Aspirin use in patients with Takotsubo Syndrome does not appear to be associated with a reduced risk of MACCE at 30 days or 5 years.
In the present study, no association was found between aspirin use in TTS patients and a reduced risk of MACCE at 30-day and 5-year follow-up. These findings should be confirmed in adequately powered randomized controlled trials. ClinicalTrials.gov Identifier: NCT01947621.
D’Ascenzo et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: